Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Structural requirements for incorporation of J chain into human IgM and IgA.

Autor: Sørensen, Vigdis, Rasmussen, Ingunn B., Sundvold, Vibeke, Michaelsen, Terje E., Sandlie, Inger

Publikováno v: International Immunology; Jan2000, Vol. 12 Issue 1, p19-27, 9p

LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.

Autor: Nielsen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Monberg T; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Sundvold V; Lytix Biopharma, Oslo, Norway., Albieri B; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hovgaard D; Department of Orthopedic Surgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Petersen MM; Department of Orthopedic Surgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Krarup-Hansen A; Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Camilio K; Lytix Biopharma, Oslo, Norway., Clancy T; NEC Oncoimmunity AS, Oslo, Norway., Stratford R; NEC Oncoimmunity AS, Oslo, Norway., Sveinbjornsson B; Lytix Biopharma, Oslo, Norway., Rekdal Ø; Lytix Biopharma, Oslo, Norway., Junker N; Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.

Publikováno v: Oncoimmunology [Oncoimmunology] 2023 Dec 07; Vol. 13 (1), pp. 2290900. Date of Electronic Publication: 2023 Dec 07 (Print Publication: 2024).